Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2296 to 2310 of 8817 results

  1. Sternoclavicular joint replacement for arthritis

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  2. Minimally invasive meshless and dissectionless anchoring system for pelvic organ prolapse repair

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  3. Percutaneous electrothermal treatment of the intervertebral disc annulus for low back pain and sciatica

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  4. Degradable surgical implant

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  5. Autologous unmanipulated peripheral blood stem cell therapy for multiple sclerosis

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  6. Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  7. Ocrelizumab for treating relapsing–remitting multiple sclerosis in people 10 to 17 years [TSID12164]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  8. Clindamycin for treating bacterial vaginosis in females aged 12 and older [TSID 12127]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  9. Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222]: draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 28 April 2026.

    Technology appraisal guidance
    In consultation

  10. Lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID4043]: draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 28 April 2026.

    Technology appraisal guidance
    In consultation

  11. Mirdametinib for treating symptomatic inoperable plexiform neurofibromas in people 2 years and over with neurofibromatosis type 1 [ID6618]

    In development Reference number: GID-TA11819 Expected publication date:  03 September 2026

    Technology appraisal guidance
    In development

  12. Larotrectinib for treating NTRK fusion-positive advanced solid tumours (MA review of TA630) [ID6292]

    In development Reference number: GID-TA11565 Expected publication date: TBC

    Technology appraisal guidance
    In development

  13. Fianlimab with cemiplimab for untreated unresectable advanced melanoma or adjuvant treatment of completely resected high-risk melanoma [ID6721]

    Awaiting development Reference number: GID-TA11929 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Neuromodulation for chronic pelvic pain

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  15. Transcatheter valve-in-valve implantation for the treatment of Tricuspid valve

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation